Composition and Methods for the Prevention of Aminoglycoside Toxicity
AssigneeTing Therapeutics LLC
InventorsJian Zuo, Marisa Laura Zallocchi
Life of this patent
Estimating the term…
Loading patent…
AssigneeTing Therapeutics LLC
InventorsJian Zuo, Marisa Laura Zallocchi
Estimating the term…
The present invention relates to therapeutic uses of active agents such as for treating, inhibiting, and/or preventing damage associated with aminoglycoside toxicity. The data establishes that piperlongumine can protect hair cells from aminoglycoside damage within a wide range of concentrations. The range is 0.1 pM to 25 uM. Furthermore, piperlongumine protects renal function, it has a good therapeutic index (TI>200,000), no interference with AG's anti-bacterial activity, and no drug-drug interaction. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
A method to prevent aminoglycoside toxicity comprising systemically co-administering to an animal or human, an aminoglycoside and an effective amount of piperlongumine to prevent aminoglycoside toxicity.
A method of preventing aminoglycoside toxicity, the method comprising administering a therapeutically effective amount of an active agent to downregulate TRPV1, or a pharmaceutically acceptable salt thereof and an aminoglycoside, wherein the active agent is selected from the group consisting of:
A formulation for systemic administration to a subject comprising:
A kit comprising:
A kit comprising:
Dependencies are inferred from the claim text.